Article
Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial.
Diabetes care - 1 Nov 2016
Shah Hetal S, Gao He, Morieri Mario Luca, Skupien Jan, Marvel Skylar, Paré Guillaume, Mannino Gaia C, Buranasupkajorn Patinut, Mendonca Christine, Hastings Timothy, Marcovina Santica M, Sigal Ronald J, Gerstein Hertzel C, Wagner Michael J, Motsinger-Reif Alison A, Buse John B, Kraft Peter, Mychaleckyj Josyf C, Doria Alessandro
Abstract excerpt
OBJECTIVE: To identify genetic determinants of increased cardiovascular mortality among subjects with type 2 diabetes who underwent intensive glycemic therapy in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. RESEARCH DESIGN AND METHODS: A total of 6.8 million common variants were analyzed for genome-wide association with cardiovascular mortality among 2,667 self-reported white subjects in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
